From: Methylphenidate use and misuse among medical residents in Israel: a cross-sectional study
 | Mean (SD) |
---|---|
Age | 36.5 (3.35) Range: 28–51 |
 | n (%) |
---|---|
Gender | |
 Female | 217 (63.5) |
Country of birth | |
 Israel | 279 (81.6) |
Native language | |
 Hebrew | 263 (76.9) |
Number of children | |
 0 | 62 (18.1) |
 1–3 | 280 (81.9) |
Residency | |
 Surgery | 90 (26.3) |
 Pediatrics/internal medicine | 99 (28.9) |
 Family medicine | 96 (28.1) |
 Other | 57 (16.7) |
Past diagnosis with ADHD | |
 Yes | 57 (16.7) |
ASRS | |
 Positive | 93 (27.2) |
Use of MPH (ever) | |
 Yes | 176 (51.5) |
Use of MPH (during residency) | |
 Yes | 172 (50.3) |
First use of MPH | |
 School | 11 (6.3) |
 Pre-clinical years of medical school | 40 (22.7) |
 Clinical years of medical school | 41 (23.3) |
 Residency | 84 (47.7) |